Zobrazeno 1 - 10
of 9 015
pro vyhledávání: '"Early breast cancer"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract ER+/HER2- breast cancer is a common subtype of breast cancer. This study aimed to evaluate the prognostic value of ER-to-PR difference (EPD) in ER+/HER2- early breast cancer (EBC). A retrospective cohort study was conducted, including 3,340
Externí odkaz:
https://doaj.org/article/b16147e007f44f32951bcb67ae88a6e0
Autor:
Ali Hasan Abdulla, Reem Althawadi, Ahmed Zuhair Salman, Tareq Hamed Altaei, Amina Mohamed Mahdi, Hussain Adnan Abdulla
Publikováno v:
European Journal of Breast Health, Vol 20, Iss 4, Pp 270-276 (2024)
Objective: The Sentinel Node vs. Observation After Axillary Ultra-Sound (SOUND) trial reported that omission of axillary surgery was not inferior to sentinel lymph node biopsy (SLNB) in those with cT1 breast cancer and negative preoperative axillary
Externí odkaz:
https://doaj.org/article/72e33a26a1d54c60a902acfbe25c1383
Autor:
Jenna Dean, Nigel Anderson, Georgia K. B. Halkett, Jessica Lye, Mark Tacey, Farshad Foroudi, Michael Chao, Caroline Wright
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Accelerated partial breast irradiation (APBI) is an accepted treatment option for early breast cancer. Treatment delivered on the Magnetic Resonance integrated Linear Accelerator (MRL) provides the added assurance of improved soft
Externí odkaz:
https://doaj.org/article/14887af25877477983b15caa0fb588e7
Autor:
Jiahui Ren, Yili Li, Jing Zhou, Ting Yang, Jingfeng Jing, Qian Xiao, Zhongxu Duan, Ke Xiang, Yuchen Zhuang, Daxue Li, Han Gao
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract This study aimed to compare the long-term outcomes of breast-conserving surgery plus radiotherapy (BCS + RT) and mastectomy in early breast cancer (EBC) patients who received neoadjuvant systemic therapy (NST), and sought to construct and au
Externí odkaz:
https://doaj.org/article/d09592c6be404a48837987e563c07ac2
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 517-527 (2024)
Kaitlyn O’Keefe, Neelam V Desai, Antoinette R Tan Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USACorrespondence: Antoinette R Tan, Depa
Externí odkaz:
https://doaj.org/article/be056c6ba056409ea620b5f2995cf652
New Insight for Axillary De-Escalation in Breast Cancer Surgery: 'SoFT Study' Retrospective Analysis
Autor:
Gianluca Vanni, Marco Materazzo, Floriana Paduano, Marco Pellicciaro, Giordana Di Mauro, Enrica Toscano, Federico Tacconi, Benedetto Longo, Valerio Cervelli, Massimiliano Berretta, Oreste Claudio Buonomo
Publikováno v:
Current Oncology, Vol 31, Iss 8, Pp 4141-4157 (2024)
Background: The SOUND study demonstrated that an axillary de-escalation may be sufficient in locoregional and distant disease control in selected early breast cancer (EBC) patients. To establish any preoperative variables that may drive sentinel lymp
Externí odkaz:
https://doaj.org/article/182c46d9fb4f45af934cec4b5438d36f
Autor:
Fabio Canino, Monica Barbolini, Ugo De Giorgi, Tommaso Fontana, Valeria Gaspari, Caterina Gianni, Lorenzo Gianni, Antonio Maestri, Santino Minichillo, Luca Moscetti, Antonella Mura, Stefania Vittoria Luisa Nicoletti, Claudia Omarini, Rachele Pagani, Samanta Sarti, Angela Toss, Claudio Zamagni, Riccardo Cuoghi Costantini, Federica Caggia, Giuseppina Antonelli, Federica Baglio, Lorenzo Belluzzi, Giulio Martinelli, Salvatore Natalizio, Ornella Ponzoni, Massimo Dominici, Federico Piacentini
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract Background The addition of pertuzumab (P) to trastuzumab (H) and standard chemotherapy (CT) as neoadjuvant treatment (NaT) for patients with HER2 + breast cancer (BC), has shown to increase the pathological complete response (pCR) rate, with
Externí odkaz:
https://doaj.org/article/1ac6fc48a61047d696aefc89f35bee02
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: Adjuvant endocrine treatment (AET) is crucial in early oestrogen receptor (ER)-positive breast cancer (BC), providing reduced recurrence rate and increased overall survival. The aim of this study was to estimate AET adherence
Externí odkaz:
https://doaj.org/article/17782af2adae4a31bed8b54b89e66639
Autor:
Daniele Generali, Andrea Rocca, Carla Strina, Manuela Milani, Enrico Fiorino, Valeria Cervoni, Carlo Azzini, Antonella Saracino, Ingnazio Ciliberto, Nicoletta Ziglioli, Marzia Alberio, Fabiola Giudici, Martina Dester, Oriana Ciani, Giulia Fornaro, Sergio Aguggini, Christa Dreezen, Darina Pronin, Stefanie Ende
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39485- (2024)
Purpose: The aim of this study was to assess the prognostic performance of the 70-gene signature, MammaPrint, in an Italian single-center prospective cohort of early-stage intermediate-risk breast cancer (BC) patients. Methods: A total of 195 eligibl
Externí odkaz:
https://doaj.org/article/2786ca856aa34c789634138ba4c8b901
Autor:
K. S. Titov, I. N. Lebedinskiy, I. N. Kuts, Sh. R. Dzhamilov, A. S. Sukhotko, Z. V. Lorie, Z. A. Bagateliya, S. S. Lebedev, D. N. Grekov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 20, Iss 1, Pp 52-58 (2024)
Modern diagnostic methods with more accurate staging of the tumor process and effective high-tech treatment of breast cancer are very relevant, since this disease ranks first in the structure of cancer morbidity and mortality among women. Mapping of
Externí odkaz:
https://doaj.org/article/14b8237d12664c77a8fdaf27bea2a122